Adverse Effects of β-Blocker Therapy for Patients With Heart Failure | Zendy

Dennis T. Ko | Zendy; Patricia R. Hebert | Zendy; Christopher S. Coffey | Zendy; Jeptha P. Curtis | Zendy; JoAnne M. Foody | Zendy; Artyom Sedrakyan | Zendy; Harlan M. Krumholz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adverse Effects of β-Blocker Therapy for Patients With Heart Failure

Author(s) -

Dennis T. Ko,

Patricia R. Hebert,

Christopher S. Coffey,

Jeptha P. Curtis,

JoAnne M. Foody,

Artyom Sedrakyan,

Harlan M. Krumholz

Publication year - 2004

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.164.13.1389

Subject(s) - medicine , adverse effect , bradycardia , beta blocker , heart failure , placebo , confidence interval , relative risk , randomized controlled trial , cardiology , anesthesia , blood pressure , heart rate , alternative medicine , pathology

Beta-blockers substantially improve survival in patients with chronic heart failure (HF) with left ventricular systolic dysfunction, but concerns about cardiovascular adverse effects may deter physicians from prescribing this therapy. We performed an overview of randomized beta-blocker trials in patients with HF to quantify the risks of these adverse effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research